Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized controlled trial
| Autor: | Stroup, T. Scott, Byerly, Matthew J., Nasrallah, Henry A., Ray, Neepa, Khan, Ahsan Y., Lamberti, J. Steven, Glick, Ira D., Steinbook, Richard M., McEvoy, Joseph P., Hamer, Robert M. |
|---|---|
| Zdroj: | In Schizophrenia Research May 2013 146(1-3):190-195 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect